ID: ALA4174012

Max Phase: Preclinical

Molecular Formula: C18H20N4S

Molecular Weight: 324.45

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCN(CC)CC#CCN1c2ccncc2Sc2ccncc21

Standard InChI:  InChI=1S/C18H20N4S/c1-3-21(4-2)11-5-6-12-22-15-7-9-20-14-18(15)23-17-8-10-19-13-16(17)22/h7-10,13-14H,3-4,11-12H2,1-2H3

Standard InChI Key:  PIXVLOPICARADS-UHFFFAOYSA-N

Associated Targets(Human)

C32 251 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 324.45Molecular Weight (Monoisotopic): 324.1409AlogP: 3.42#Rotatable Bonds: 4
Polar Surface Area: 32.26Molecular Species: BASEHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.82CX LogP: 2.62CX LogD: 1.06
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.80Np Likeness Score: -1.15

References

1. Pluta K, Jeleń M, Morak-Młodawska B, Zimecki M, Artym J, Kocięba M, Zaczyńska E..  (2017)  Azaphenothiazines - promising phenothiazine derivatives. An insight into nomenclature, synthesis, structure elucidation and biological properties.,  138  [PMID:28734245] [10.1016/j.ejmech.2017.07.009]

Source